Becton, Dickinson and Company

Becton, Dickinson and Company — FDA 510(k) Submissions

Becton, Dickinson and Company has submitted 130 FDA 510(k) premarket notifications since 2010, of which 130 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Tubes, Vials, Systems, Serum Separators, Blood Collection, System, Test, Automated, Antimicrobial Susceptibility, Short Incubation, Syringe, Piston, Needle, Hypodermic, Single Lumen, Devices Detecting Influenza A, B, And C Virus Antigens . Use the specialty filter in the sidebar to narrow results.